نبذة مختصرة : Aim: The primary aim of the study was to determine the incidence of testicular neoplasms in the Zenica-Doboj Canton (ZDC) region for the period from 2019 to 2021. Also, the study aimed to examine the age structure of the affected population, the frequency of testicular neoplasms in all the ZDC cities and municipalities, and the pathohistological characteristics of neoplasms. Material and methods: The study was conducted at the Oncology and Radiotherapy Department of the Zenica Cantonal Hospital. The study period refers to the time interval from January 2019 to December 2021. The study included 37 patients with a verified diagnosis of testicular neoplasm. Results: Arithmetic mean of patients’ age was 33.49 years, while the standard deviation was 12.59. Most respondents, accounting for 40.5%, were aged 26-35 years. The incidence of testicular neoplasms in the ZDC region was 4.2/100,000 persons in 2019, 3.08/100,000 persons in 2020, and 3.10/100,000 persons in 2021. Most diagnosed neoplasms (48.6%) were the myxoid type germ cell originating tumors. Conclusion: The incidence of testicular neoplasms in the ZDC was 4.2/100,000 persons in 2019, 3.08/100,000 persons in 2020, and 3.10/100,000 persons in 2021. ; Cilj: Osnovni cilj istraživanja je utvrditi incidenciju neoplazmi testisa na području Zeničko-dobojskog kantona za razdoblje od 2019. do 2021. godine. Također, cilj je bio ispitati dobnu strukturu oboljele populacije, učestalost neoplazme testisa u svim gradovima Zeničko-dobojskog kantona, te patohistološke karakteristike neoplazmi. Materijal i metode: Istraživanje je provedeno na Odjelu za onkologiju i radioterapiju Kantonalne bolnice Zenica. Razdoblje pregleda odnosi se na vremenski interval od liječnja 2019. do prosinca 2021. Istraživanjem je obuhvaćeno 37 ispitanika s verificiranom dijagnozom neoplazme testisa. Rezultati: Aritmetička sredina bolesničkih godina bila je 33,49, a standardna devijacija 12,59. Najveći broj ispitanika pripada dobnoj kategoriji od 26-35 godina, u postotku od 40,5%. Učestalost ...
No Comments.